Investor Information

Press Releases

Resources

Legal Disclaimer

Resources

The Resources section provides additional information and links to scientific articles, newsworthy stories and market trends on a wide range of topics related to PharmaRoth Labs Inc., Type 2 diabetes, and SucanonĀ®.

.........................................................................................................................................

Type 2 Diabetes in the News

Diabetes numbers rise, CDC says - Washington Post

Zero Healthcare and Top 10 Diabetes World Ranking Make More Trouble for Egypt - Diabetes 24/7

Protecting Yourself From the Cost of Type 2 Diabetes- The New York Times

105 Million in U.S. Have Diabetes or Prediabetes, CDC Says - Business Week

Half of Americans Facing Diabetes by 2020 - Reuters

New Diabetes Figures in China - International Diabetes Foundation

Diabetes to Double or Triple in U.S. By 2050, CDC Says - Fox News

Type 2 Diabetes Resources

International Diabetes Federation

World Diabetes Foundation

American Diabetes Association

World Health Organization

Wikipedia, the free encyclopedia

Insulin Sensitizers and other Type II Diabetic Drugs

Insulin Sensitizers for Type 1 and Type 2 Diabetes
Why insulin sensitizers but not secretagogues should be retained when initiating insulin in type 2 diabetes
Review: Insulin Sensitizers
Diabetes Death Watch Slipped Into Health Law by Lilly, Novo

Home  |  Company  |  Diabetes  |  Sucanon  |  Investor Relations  |  Contact  |  Legal Disclaimer  |  Privacy Policy